Qian Ke

Qian Ke

Auto-generated profile, based on publicly available information

Qian Ke

Department of Civil and Coastal Engineering University of Florida b Bloomberg 731 Lexington Avenue 1949 Stadium Rd 32611 Gainesville New York FL US USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2024 in IEEE Transactions on Intelligent Transportation Systems
Verified
Journal Article
Open access
XZXiaojian Zhang
Xiaojian Zhang
QKQian Ke
Qian Ke
XZXilei Zhao
Xilei Zhao
Artificial Intelligence (AI) and machine learning have been increasingly adopted for travel demand forecasting. The AI-based travel demand forecasting models, though generate accurate predictions, may produce prediction biases and raise fairness issues. Using such biased models for decision-making may lead to transportation policies that exacerbate social inequalities. However, limited studies have been focused on addressing the fairness issues of these models. Therefore, in this study, we propose a novel methodology to develop fairness-aware, highly-accurate travel demand forecasting models. Particularly, the proposed methodology can enhance the fairness of AI models for multiple protected attributes (such as race and income) simultaneously. Specifically, we introduce a new fairness regularization term, which is explicitly designed to measure the correlation between prediction accuracy and multiple protected attributes, into the loss function of the travel demand forecasting model. We conduct two case studies to evaluate the performance of the proposed methodology using real-world ridesourcing-trip data in Chicago, IL and Austin, TX, respectively. Results highlight that our proposed methodology can effectively enhance fairness for multiple protected attributes while preserving prediction accuracy. Additionally, we have compared our methodology with three state-of-the-art methods that adopt the regularization term approach, and the results demonstrate that our approach significantly outperforms them in both preserving prediction accuracy and enhancing fairness. This study can provide transportation professionals with a new tool to achieve fair and accurate travel demand forecasting.

21 June 2024 in GeoInformatica
Verified
Journal Article
Closed access
PDF file
YXYiming Xu
Yiming Xu
QKQian Ke
Qian Ke
XZXiaojian Zhang
Xiaojian Zhang
XZXilei Zhao
Xilei Zhao

11 June 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
QKQian Ke
Qian Ke
WDWikum Dinalankara
Wikum Dinalankara
LYLaurent Younes
Laurent Younes
DGDonald Geman
Donald Geman
LMLuigi Marchionni
Luigi Marchionni
Cancer cells display massive dysregulation of key regulatory pathways due to now well-catalogued mutations and other DNA-related aberrations. Moreover, enormous heterogeneity has been commonly observed in the identity, frequency and location of these aberrations across individuals with the same cancer type or subtype, and this variation naturally propagates to the transcriptome, resulting in myriad types of dysregulated gene expression programs. Many have argued that a more integrative and quantitative analysis of heterogeneity of DNA and RNA molecular profiles may be necessary for designing more systematic explorations of alternative therapies and improving predictive accuracy. We introduce a representation of multi-omics profiles which is sufficiently rich to account for observed heterogeneity and support the construction of quantitative, integrated, metrics of variation. Starting from the network of interactions existing in Reactome, we build a library of “paired DNA-RNA aberrations” that represent prototypical and recurrent patterns of dysregulation in cancer; each two-gene “Source-Target Pair” (STP) consists of a “source” regulatory gene and a “target” gene whose expression is plausibly “controlled” by the source gene. The STP is then “aberrant” in a joint DNA-RNA profile if the source gene is DNA-aberrant (e.g., mutated, deleted, or duplicated), and the downstream target gene is “RNA-aberrant”, meaning its expression level is outside the normal, baseline range. With M STPs, each sample profile has exactly one of the 2M possible configurations. We concentrate on subsets of STPs, and the corresponding reduced configurations, by selecting tissue-dependent minimal coverings, defined as the smallest family of STPs with the property that every sample in the considered population displays at least one aberrant STP within that family. These minimal coverings can be computed with integer programming. Given such a covering, a natural measure of cross-sample diversity is the extent to which the particular aberrant STPs composing a covering vary from sample to sample; this variability is captured by the entropy of the distribution over configurations. We apply this program to data from TCGA for six distinct tumor types (breast, prostate, lung, colon, liver, and kidney cancer). This enables an efficient simplification of the complex landscape observed in cancer populations, resulting in the identification of novel signatures of molecular alterations which are not detected with frequency-based criteria. Estimates of cancer heterogeneity across tumor phenotypes reveals a stable pattern: entropy increases with disease severity. This framework is then well-suited to accommodate the expanding complexity of cancer genomes and epigenomes emerging from large consortia projects.

25 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
QKQian Ke
Qian Ke
WDWikum Dinalankara
Wikum Dinalankara
LYLaurent Younes
Laurent Younes
DGDonald Geman
Donald Geman
LMLuigi Marchionni
Luigi Marchionni
Cancer cells display massive dysregulation of key regulatory pathways due to now well-catalogued mutations and other DNA-related aberrations. Moreover, enormous heterogeneity has been commonly observed in the identity, frequency and location of these aberrations across individuals with the same cancer type or subtype, and this variation naturally propagates to the transcriptome, resulting in myriad types of dysregulated gene expression programs. Many have argued that a more integrative and quantitative analysis of heterogeneity of DNA and RNA molecular profiles may be necessary for designing more systematic explorations of alternative therapies and improving predictive accuracy. We introduce a representation of multi- omics profiles which is sufficiently rich to account for observed heterogeneity and support the construction of quantitative, integrated, metrics of variation. Starting from the network of interactions existing in Reactome, we build a library of “paired DNA-RNA aberrations” that represent prototypical and recurrent patterns of dysregulation in cancer; each two-gene “Source-Target Pair” (STP) consists of a “source” regulatory gene and a “target” gene whose expression is plausibly “controlled” by the source gene. The STP is then “aberrant” in a joint DNA-RNA profile if the source gene is DNA-aberrant ( e.g. , mutated, deleted, or duplicated), and the downstream target gene is “RNA-aberrant”, meaning its expression level is outside the normal, baseline range. With M STPs, each sample profile has exactly one of the 2 M possible configurations. We concentrate on subsets of STPs, and the corresponding reduced configurations, by selecting tissue-dependent minimal coverings, defined as the smallest family of STPs with the property that every sample in the considered population displays at least one aberrant STP within that family. These minimal coverings can be computed with integer programming. Given such a covering, a natural measure of cross-sample diversity is the extent to which the particular aberrant STPs composing a covering vary from sample to sample; this variability is captured by the entropy of the distribution over configurations. We apply this program to data from TCGA for six distinct tumor types (breast, prostate, lung, colon, liver, and kidney cancer). This enables an efficient simplification of the complex landscape observed in cancer populations, resulting in the identification of novel signatures of molecular alterations which are not detected with frequency-based criteria. Estimates of cancer heterogeneity across tumor phenotypes reveals a stable pattern: entropy increases with disease severity. This framework is then well-suited to accommodate the expanding complexity of cancer genomes and epigenomes emerging from large consortia projects. Author Summary: A large variety of genomic and transcriptomic aberrations are observed in cancer cells, and their identity, location, and frequency can be highly indicative of the particular subtype or molecular phenotype, and thereby inform treatment options. However, elucidating this association between sets of aberrations and subtypes of cancer is severely impeded by considerable diversity in the set of aberrations across samples from the same population. Most attempts at analyzing tumor heterogeneity have dealt with either the genome or transcriptome in isolation. Here we present a novel, multi-omics approach for quantifying heterogeneity by determining a small set of paired DNA-RNA aberrations that incorporates potential downstream effects on gene expression. We apply integer programming to identify a small set of paired aberrations such that at least one among them is present in every sample of a given cancer population. The resulting “coverings” are analyzed for six cancer cohorts from the Cancer Genome Atlas, and facilitate introducing an information-theoretic measure of heterogeneity. Our results identify many known facets of tumorigenesis as well as suggest potential novel genes and interactions of interest. Data Availability Statement: RNA-Seq data, somatic mutation data and copy number data for The Cancer Genome Atlas were obtained through the Xena Cancer Genome Browser database ( https://xenabrowser.net ) from individual cancer type cohorts. Computational functionality for the optimization procedure is provided at https://github.com/wikum/lpcover and the code for the analysis in the manuscript is provided at https://github.com/wikum/CoveringAnalysis . Processed data in the form of TAB delimited files, and selected tissue-level coverings (in excel format) are provided as additional supplementary material and are also available from the Marchionni laboratory website ( http://marchionnilab.org/signatures.html )

5 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WDWikum Dinalankara
Wikum Dinalankara
QKQian Ke
Qian Ke
DGDonald Geman
Donald Geman
LMLuigi Marchionni
Luigi Marchionni
Given the ever-increasing amount of high-dimensional and complex omics data becoming available, it is increasingly important to discover simple but effective methods of analysis. Divergence analysis transforms each entry of a high-dimensional omics profile into a digitized (binary or ternary) code based on the deviation of the entry from a given baseline population. This is a novel framework that is significantly different from existing omics data analysis methods: it allows digitization of continuous omics data at the univariate or multivariate level, facilitates sample level analysis, and is applicable on many different omics platforms. The divergence package, available on the R platform through the Bioconductor repository collection, provides easy-to-use functions for carrying out this transformation. Here we demonstrate how to use the package with data from the Cancer Genome Atlas.

13 August 2019 in bioRxiv
Verified
Preprint
Open access
WDWikum Dinalankara
Wikum Dinalankara
QKQian Ke
Qian Ke
DGDonald Geman
Donald Geman
LMLuigi Marchionni
Luigi Marchionni
Given the ever-increasing amount of high-dimensional and complex omics data becoming available, it is increasingly important to discover simple but effective methods of analysis. Divergence analysis transforms each entry of a high-dimensional omics profile into a digitized (binary or ternary) code based on the deviation of the entry from a given baseline population. This is a novel framework that is significantly different from existing omics data analysis methods: it allows digitization of continuous omics data at the univariate or multivariate level, facilitates sample level analysis, and is applicable on many different omics platforms. The divergence package, available on the R platform through the Bioconductor repository collection, provides easy-to-use functions for carrying out this transformation. Here we demonstrate how to use the package with data from the Cancer Genome Atlas.